Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: Demographics, circumstances, toxicology and major organ pathology

Drug and Alcohol Dependence

Volumn 104, Issue 3, 2009, Pages 254-261

  Kaye, Sharlene ^a   Darke, Shane ^a   Duflou, Johan ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cardiovascular; Death; Ecstasy; Fatalities; MDMA; Pathology

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADOLESCENT; ADULT; ARTICLE; ATHEROSCLEROSIS; AUSTRALIA; BRAIN DAMAGE; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; DEMOGRAPHY; DRUG INTOXICATION; FEMALE; FORENSIC PATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOLOGICAL ANATOMY; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; AUSTRALIA; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CEREBROVASCULAR DISORDERS; EMPLOYMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SEX FACTORS; STREET DRUGS; SUICIDE; WOUNDS AND INJURIES;

EID: 68549112717     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.05.016     Document Type: Article

References (52)

1. Albertson T.E., Derlet R.W., and Van Hoozen B.E. Methamphetamine and the expanding complications of amphetamines. West. J. Med. 170 (1999) 214-219
2. Australian Institute of Health Welfare. 2007 National Drug Strategy Household Survey: First Results. Drug Statistics Series No. 20 (2008), AIHW, Canberra AIHW cat. no. PHE 66
3. Bailey D.N., and Shaw R.F. Cocaine- and methamphetamine-related deaths in San Diego County (1987): homicides and accidental overdoses. J. Forensic Sci. 34 (1989) 407-422
4. Baylen C., and Rosenberg H. A review of the acute subjective effects of MDMA/ecstasy. Addiction 101 (2006) 933-947
5. Burgess C., O'Donohoe A., and Gill M. Agony and ecstasy: a review of MDMA effects and toxicity. Eur. Psychiatry 15 (2000) 287-294
6. Coffin P.O., Galea S., Ahern J., Leon A.C., Vlahov D., and Tardiff K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction 98 (2003) 739-747
7. Cohen R.S. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy"). Biol. Psychiatry 39 (1996) 819-820
8. Darke S., Degenhardt L., and Mattick R. Mortality amongst Illicit Drug Users (2007), Cambridge University Press, Cambridge
9. Darke S., Kaye S., and Duflou J. Cocaine-related fatalities in New South Wales, Australia 1993-2002. Drug Alcohol Depend. 77 (2005) 107-114
10. Degenhardt L., and Dunn M. Ecstasy. In: Ross J. (Ed). Illicit Drug use in Australia: Epidemiology, Use Patterns and Associated Harm. 2nd edition (2007), Commonwealth of Australia, Canberra 37-44
11. Degenhardt L., and Roxburgh A. 2005 Cocaine and Methamphetamine related Drug-induced Deaths in Australia (2007), National Drug and Alcohol Research Centre, Sydney
12. Degenhardt L., and Roxburgh A. Accidental Drug-induced Deaths due to Opioids in Australia, 2005 (2007), National Drug and Alcohol Research Centre, Sydney
13. Duflou J., and Mark A. Aortic dissection after ingestion of "ecstasy" (MDMA). Am. J. Forensic Med. Pathol. 21 (2000) 261-263
14. Gable R.S. Acute toxic effects of club drugs. J. Psychoactive Drugs 36 (2004) 303-313
15. Gill J., Hayes J., deSouza I., Marker E., and Stajic M. Ecstasy (MDMA) deaths in New York City: a case series and review of the literature. J. Forensic Sci. 47 (2002) 121-126
16. Gouzoulis-Mayfrank E., and Daumann J. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. J. Psychopharmacol. (Oxf.) 20 (2006) 188-193
17. Gowing L., Henry-Edwards S., Irvine R., and Ali R. The health effects of ecstasy: a literature review. Drug Alcohol Rev. 21 (2002) 53-63
18. Hall A.P., and Henry J.A. Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. Br. J. Anaesth. 96 (2006) 678-685
19. Kalant H. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. CMAJ 165 (2001) 917-928
20. Kalant H., and Kalant O.J. Death in amphetamine users: causes and rates. Can. Med. Assoc. J. 112 (1975) 299-304
21. Karch S.B. Karch's Pathology of Drug Abuse (2002), CRC Press, Boca Raton
22. Karch S.B., Stephens B.G., and Ho C.H. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicological profiles. J. Forensic Sci. 44 (1999) 359-368
23. Kaye S., and Darke S. Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia [see comment]. Addiction 99 (2004) 1315-1322
24. Kaye S., Darke S., Duflou J., and McKetin R. Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology. Addiction 103 (2008) 1353-1360
25. Kaye S., McKetin R., Duflou J., and Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 102 (2007) 1204-1211
26. Lai T., Hwang J., Fang C., and Chen W. Methylene 3,4 dioxymethamphetamine-induced acute myocardial infarction. Ann. Emerg. Med. 42 (2003) 759-762
27. Lester S., Baggott M., Welm S., Schiller N., Jones R., and Foster E. Cardiovascular effects of 3,4-methylenedioxymethamphetamine. Ann. Intern. Med. 133 (2000) 969-973
28. Libiseller K., Pavlic M., Grubwieser P., and Rabl W. Ecstasy-deadly risk even outside rave parties. Forensic Sci. Int. 153 (2005) 227-230
29. Liechti M., Kunz I., and Kupferschmidt H. Acute medical problems due to Ecstasy use. Swiss Med. Weekly 135 (2005) 652-657
30. Logan B., Fligner C.L., and Haddix T. Cause and manner of death in fatalities involving methamphetamine. J. Forensic Sci. 43 (1998) 28-34
31. Lora-Tamayo C., Tena T., and Rodriguez A. Amphetamine derivative related deaths. Forensic Sci. Int. 85 (1997) 149-157
32. Mendelson J., Jones R.T., Upton R., and Jacob P. Methamphetamine and ethanol interactions in humans. Clin. Pharmacol. Ther. 57 (1995) 559-568
33. Milroy C., Clark J., and Forrest A. Pathology of deaths associated with "ecstasy" and "eve" misuse. J. Clin. Pathol. 49 (1996) 149-153
34. Patel M., Belson M., Wright D., Lu H., Heninger M., and Miller M. Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: an autopsy study. Resuscitation 66 (2005) 197-202
35. Patel M., Wright D., Ratcliff J., and Miller M. Shedding new light on the "safe" club drug: methylenedioxymethamphetamine (ecstasy)-related fatalities. Acad. Emerg. Med. 11 (2004) 208-210
36. Patel M.M., Belson M.G., Longwater A.B., Olson K.R., and Miller M.A. Methylenedioxymethamphetamine (ecstasy)-related hyperthermia. J. Emerg. Med. 29 (2005) 451-454
37. Petitti D., Sidney S., Quesenberry C., and Bernstein A. Stroke and cocaine or amphetamine use. Epidemiology 9 (1998) 596-600
38. Qasim A., Townend J., and Davies M. Ecstasy induced acute myocardial infarction. Heart 85 (2001) e10
39. Quinn C., Breen C., and White B. Illicit Tablet Market in Victoria. Party Drug Trends Bulletin (2004, June), National Drug and Alcohol Research Centre, Sydney
40. Raikos N., Tsoukali H., Psaroulis D., Vassiliadis N., Tsoungas M., and Njau S. Amphetamine derivative related deaths in northern Greece. Forensic Sci. Int. 128 (2002) 31-34
41. Rosenson J., Smollin C., Sporer K., Blanc P., and Olson K. Patterns of ecstasy-associated hyponatremia in California. Ann. Emerg. Med. 49 (2007) 164-171
42. Schifano F. A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology 173 (2004) 242-248
43. Schifano F., Corkery J., Deluca P., Oyefeso A., and Ghodse A. Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003) (United kingdom). J. Psychopharmacol. (Oxf.) 20 (2006) 456-463
44. Schifano F., Oyefeso A., Corkery J., Cobain K., Jambert-Gray R., Martinotti G., and Ghodse A. Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002. Hum. Psychopharmacol. 18 (2003) 519-524
45. Schifano F., Oyefeso A., Webb L., Pollard M., Corkery J., and Ghodse A. Review of deaths related to taking ecstasy, England and Wales, 1997-2000. BMJ 326 (2003) 80-81
46. SPSS Inc. SPSS for Windows, Rel. 14.0.2 (2006), SPSS Inc., Chicago
47. Stafford J., Sindicich N., and Burns L. An overview of the 2008 EDRS: the regular ecstasy user survey findings. EDRS Drug Trends Bulletin (2008, December), National Drug and Alcohol Research Centre, Sydney
48. Tardiff K., Marzuk P.M., Leon A.C., Portera L., Hartwell N., Hirsch C.S., and Stajic M. Accidental fatal drug overdoses in New York City: 1990-1992. Am. J. Drug Alcohol Abuse 22 (1996) 135-146
49. Topp L., Hando J., Dillion P., Roche A., and Solowij N. Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend. 55 (1999) 105-115
50. Westover A.N., McBride S., and Haley R.W. Stroke in young adults who abuse amphetamines or cocaine. Arch. Gen. Psychiatry 64 (2007) 495-502
51. Wetli C.V., and Wright R.K. Death caused by recreational cocaine use. JAMA 241 (1979) 2519-2522
52. Zhu B.L., Oritani S., Shimotouge K., Ishida K., Quan L., Fujita M.Q., Ogawa M., and Maeda H. Methamphetamine-related fatalities in forensic autopsy during 5 years in the southern half of Osaka city and surrounding areas. Forensic Sci. Int. 113 (2000) 443-447